Cargando…

Clinical commentary on ‘Cortical ischemic lesions from atrial myxoma as a mimic of disease activity in a RRMS antiCD20-treated patient’

Detalles Bibliográficos
Autor principal:	Chard, Declan T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Report and Clinical Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637106/ https://www.ncbi.nlm.nih.gov/pubmed/37712391 http://dx.doi.org/10.1177/13524585231195354

Ejemplares similares

Commentary: The immunologic mystery of cardiac myxoma
por: Al-Ameri, Ali, et al.
Publicado: (2020)

Commentary: Cutaneous presentation of cardiac myxoma
por: Gerlach, Rebecca M., et al.
Publicado: (2020)

Commentary: Altruism reveals a surreptitious life-threatening myxoma
por: Abdullah, Ibrahim
Publicado: (2020)

Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies
por: Bellinvia, Angelo, et al.
Publicado: (2022)

Cortical Pathology in RRMS: Taking a Cue from Four Sisters
por: Calabrese, Massimiliano, et al.
Publicado: (2012)

Atrial Myxoma – An unusual cause of ischemic stroke in young
por: Sohal, Ravdeep Singh, et al.
Publicado: (2020)

Subarachnoid Hemorrhage Following Ischemic Stroke Caused by Atrial Myxoma
por: Chen, Chao, et al.
Publicado: (2021)

Atrial Myxoma: An Unusual Etiology of Ischemic Stroke in an Adult Patient
por: Sadia, Haleema, et al.
Publicado: (2023)

The MRI central vein marker; differentiating PPMS from RRMS and ischemic SVD
por: Samaraweera, Amal P.R., et al.
Publicado: (2018)

Commentary: Targeting the left atrial appendage
por: Gillinov, Marc, et al.
Publicado: (2021)

Commentary: Atrial fibrillation? Go hybrid
por: Moscarelli, Marco, et al.
Publicado: (2021)

Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T Cells
por: Zhu, Mei, et al.
Publicado: (2021)

Multiple Metastatic Intracranial Lesions Associated with Left Atrial Myxoma
por: Kierdaszuk, Biruta, et al.
Publicado: (2014)

Heart or head?: A depression mimic delays diagnosis—oncotic cerebral aneurysms caused by atrial myxoma
por: Connolly, Bridgid, et al.
Publicado: (2017)

Myxoma Mimic in a Patient With Acute Myeloid Leukemia
por: Campo-Rivera, Natalia, et al.
Publicado: (2023)

Oral available agents in the treatment of RRMS
por: Aupérin, Thierry
Publicado: (2013)

Commentary: 20 years online with “Your Disease Risk”
por: Colditz, Graham A., et al.
Publicado: (2020)

Commentary: Combination surgery for ischemic cardiomyopathy: The preemptive strike
por: Glower, Donald D.
Publicado: (2021)

EDSS and infratentorial white matter lesion volume are considered predictors of fatigue severity in RRMS
por: Ezzeldin, Mohammed Y., et al.
Publicado: (2023)

P1187: SAFETY AND EFFICACY OF ANTICD20-CD3 BISPECIFIC T-CELL ENGAGING ANTIBODIES IN THE MANAGEMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS
por: Rahman, Mansoor, et al.
Publicado: (2023)

AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells
por: Fan, Dongmei, et al.
Publicado: (2015)

Intravenous thrombolysis in a patient with left atrial myxoma with acute ischemic stroke
por: Kulkarni, Girish Baburao, et al.
Publicado: (2014)

Intravenous thrombolysis in a patient with left atrial myxoma with acute ischemic stroke
por: Kulkarni, Girish Baburao, et al.
Publicado: (2015)

Giant left atrial myxoma causing acute ischemic stroke in a child
por: Ise, Hayato, et al.
Publicado: (2018)

Recurrent Ischemic Stroke in a Patient with Atrial Myxoma: A Case Report
por: Shrestha, Gentle Sunder, et al.
Publicado: (2022)

Translational Biophysics – 20(th) IUPAB Congress Session Commentary
por: Perez-Gil, Jesus, et al.
Publicado: (2021)

Commentary: Another step forward ischemic mitral regurgitation comprehension
por: Di Mauro, Michele, et al.
Publicado: (2020)

Commentary: Ocular lesions in leprosy – Should we forget?
por: Biswas, Jyotirmay, et al.
Publicado: (2022)

Reduced Expression of PD-1 in Circulating CD4+ and CD8+ Tregs Is an Early Feature of RRMS
por: Machcińska, Maja, et al.
Publicado: (2022)

Disappearing “Myxoma”: Left Atrial Thrombus Masquerading as a Myxoma
por: Antwi-Amoabeng, Daniel, et al.
Publicado: (2020)

Commentary: Juxtaposition of the atrial appendages: Fatal attraction or benign coupling?
por: Abdullah, Ibrahim
Publicado: (2021)

MS Cortical Lesions on DIR: Not Quite What They Seem?
por: Sethi, Varun, et al.
Publicado: (2013)

Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS
por: Ghezzi, Angelo, et al.
Publicado: (2019)

Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS only
por: Kalra, S, et al.
Publicado: (2020)

A colossal atrial myxoma
por: Rohani, Atoosheh, et al.
Publicado: (2010)

Right Atrial Myxoma and Syncope
por: Animashaun, Islamiyat Babs, et al.
Publicado: (2015)

Atrial mass: a myxoma?
por: Chatzis, Andrew C., et al.
Publicado: (2016)

Neovascularization in Left Atrial Myxoma
por: Dubey, Laxman, et al.
Publicado: (2012)

Extracardiac manifestations of atrial myxomas
por: Thyagarajan, Braghadheeswar, et al.
Publicado: (2017)

Obstructive neonatal atrial myxoma
por: Iezzi, Federica, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1u4qgbopauh04hfm7d3c67qflj